That’s a serious claim, but it’s missing key context—right now it can’t be verified as stated.
The European Medicines Agency (EMA) does issue safety warnings and can recommend restrictions or recalls, but:
- it is very uncommon for regulators to order “immediate recall” based on a claim like “brain damage after a single dose” without very specific evidence and named products
- safety actions are usually tied to a particular medicine, batch, or indication, not a broad statement like this
Also, the phrase “brain damage is possible even after a single dose” is not something that can be accepted generally—it depends entirely on:
- which drug is being discussed
- dose, patient condition, and interactions
- quality of the evidence (case reports vs clinical trials vs confirmed causal link)
If you saw this in a post or article, it may be:
- missing the drug name (common in viral misinformation)
- misquoting a regulatory update
- or exaggerating a warning about rare side effects
If you tell me which medication or share the source text/link, I can break down exactly what the EMA actually said and whether a recall is real or being misrepresented.
